82.1 F
San Fernando
Friday, Mar 29, 2024

Clinical Trial to Start for Amgen Drug

The biopharmaceutical company Amgen has started the largest clinical trial to date of patients with stage five chronic kidney disease. The late-stage trial focuses on Amgen’s Sensipar/Mimpara, enrolling about 3,800 patients at 500 sites worldwide. Amgen is based in Thousand Oaks.

Featured Articles

Related Articles